ABSTRACT. The metabolism of branched-chain amino acids was studied in cultured fibroblasts from patients with branched-chain ketoacid dehydrogenase deficiency using 1-I4C-and UL-14C-leucine and valine. The formation of I4CO2 from 1-14C-valine or l-14C-leucine was 1-3% of normal. In fibroblasts of patients with associated lactic acidemia the values were 4-29% of control. Analysis of organic acid products revealed that in both patients and controls the amount of labeled a-ketoisovalerate recovered after incubation with l-14C-valine was one-third of the amount of a-ketoisocaproate recovered after incubation with I-"C-leucine. Very little a-hydroxyisocaproate was produced, while the amount of a-hydroxyisovalerate was about 10% of the a-ketoisovalerate. Unexpectedly P-hydroxyisobutyrate ws found to be the major metabolic product of UL-14C-valine in normal fibroblasts. Large accumulations of P-hydroxyisovalerate were found in normal fibroblasts using UL-14C-leucine. There were little or no conversions to these compounds in fibroblasts of patients with branched-chain ketoacid dehydrogenase deficiency. There were substantial conversions in the patients in whom dehydrogenase deficiency was associated with lactic acidemia. (Pediatr Res 20: 169-174, 1986) Abbreviations BCKADI-I, branched-chain ketoacid dehydrogenase MSUD, maple syrup urine disease E3, dihydrolipoyl dehydrogenase LPC, liquid partition chromatography MSUD results from defective activity of the BCKADH complex (1). The concentrations of leucine in the blood of patients with MSUD are generally higher than those of valine and isoleucine, indicating that there are differences in metabolism among the three ketoacids. Several variant forms of BCKADH deficiency have been described (2-4). Patients have also been described in whom deficiency of BCKADH was secondary to a deficiency of E3 (5, 6). We have also studied a patient in whom
there was deficiency of the activities of BCKADH, pyruvate dehydrogenase and a-ketoglutarate dehydrogenase in whom the activity of E3 was normal (Yoshida I, Sweetman L, Nyhan WL,, Robinson 
BH, unpublished data).
We have studied the metabolic pathways of the branchedchain amino acids to C 0 2 and to organic acid reaction products in fibroblasts of patients with different types of defects in the activity of BCKADH.
MATERIALS AND METHODS

Materials.
Thiamine. HCI, bovine serum albumin, and glucose were obtained from Sigma Company, St. Louis, MO. 1-I4C-rleucine (53.7 mCi/mmol) and 1-14C-L-valine (47.9 mCi/mmol) were obtained from New England Nuclear, Boston, MA. UL,-I4C-L-leucine (300 mCi/mmol) and UL-14C-L-valine (250 mCi/ mmol) were obtained from ICN Pharmaceuticals, Inc., Irvine, CA. Unlabeled L-amino acids were obtained from Calbiochern, La Jolla, CA. P-Phase liquid scintillation fluid was purchaseld from Westchem Products, San Diego, CA; and Cab-0-Sil thixotropic gel powder from Packard, Downers Grove, IL. Silicic acild (100 mesh suitable for chromatography) was purchased frorn Mallinkrodt, Paris, KY, dried overnight at 130" C and silicic acid was prepared for column chromatography by mixing 92 g with 50 ml 0.05 mol/liter sulfuric acid. Other chemicals were reagent grade.
Cell lines and conditions of culture. Human fibroblasts were cultured from skin biopsies of normal subjects (FS1, 2, 3, and 5 ) and patients with defects in BCKADH. Fibroblasts of a patient with classical MSUD (GM 6 12) were obtained from the Human Genetic Mutant Cell Repository, Camden, NJ. Three patien1.s had the clinical phenotype of the intermittent form of BCKADIl (CH, SR, and KF) (1, 2). One patient (TK) (5) had a deficiency of E3. EB (Yoshida I, Sweetman L, Nyhan WL, Robinson BF[, unpublished data) had branched-chain ketoaciduria, lactic acidemia, and a-ketoglutaric aciduria, but the activity of E3 was normal. Fibroblasts were cultured in roller bottles in Eagle"s minimal essential medium with 10% fetal calf serum and penicillin and streptomycin. The cells were harvested using trypsin-EDTA, suspended in minimal essential medium-10% fetal calf serum, counted, washed three times with isotonic Krebs-Ringer phosphate buffer (7) by centrifugation, and resuspended at a concentration of 2 x 10%ells in 280 ~1 of buffer containing 5.55 mmol/liter glucose and 1 mg/ml of bovine serum albumin. Krebs-Ringer phosphate buffer pH 7.4 was used for studies of 1 -I4C-amino acids and Krebs-Ringer bicarbonate buffer pH 7.4 was used for studies of UL-'4C-amino acids. The addition of 1 mg/ml of bovine serum albumin to the incubations increased the number of intact cells remaining after 90 min of incubation.
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YOSHIDA ET AL The addition of 5.55 mmol/liter of glucose increased the I4CO2 production from I-14C-leucine in normal cells by more than 2-fold.
Studies of the metuholism of I-14C-leucine and I-14C-valine.
Assays for the oxidation of I-14C-labeled branched-chain amino acids to I4CO2 were modified from Dancis el al. (4) . Incubations were done in a total volume of 300 PI in vials containing plastic cups suspended through rubber caps for the trapping of C02. The standard incubation contained 2 x lo6 cells, 280 of KrebsRinger phosphate buffer with 5.55 mmol/liter glucose, 1 mg/ml bovine serum albumin, 5 of thiamine. HC1 (final concentration 5 mmol/liter), and 15 p1 of I-14C-leucine or 1-I4C-valine with a specific activity of 0.4 mCi/mmol to give a final concentration of 1 mmol/liter. The blanks were incubated without cells. After incubation for 90 min at 35" C in a shaking water bath, the incubation vials were placed on ice. To acidify the incubations and evolve I4CO2, 25 p1 of 6 mol/liter sulfuric acid were injected into the incubation mixture and 400 pl of 3 mol/liter KOH were injected into the suspended cup. After trapping I4CO2 for 1 h while the vials were on ice, the KOH was transferred to scintillation vials and each cup rinsed two times with 500 PI of H20. Bray's liquid scintillation fluid with 3% Cab-0-Sil (I 5 ml) (8) was added, and the vials counted in a Beckman LS250 Scintillation Spectrophotometer with external standardization for quenching. The acidified assay mixtures were stored at -20°C until analyzed for a-keto and a-hydroxy acids by LPC modified from Sweetman (9) . The acidified samples to which were added I micromole of each of the appropriate unlabeled a-keto and ahydroxy acids were adsorbed onto dried silicic acid and placed on a 0.6 cm 1D x 45 cm column of hydrated silicic acid and eluted with 1% (v/v) 2-methyl-2-butanol in chloroform at 2.5 ml/min. The cmuent was titrated spectrophotometrically by mixing with 0.5 ml/min of 5 mmol/liter Na o-nitrophenolate in 95% ethanol, and twenty 2 min fractions were collected. The fractions were dried overnight under a heat lamp in a hood. The dried fractions were dissolved in 0.5 ml of 35 mmol/liter acetic acid to decolorize the indicator and counted in 5 ml of P-phase liquid scintillation fluid.
Stzlu'ics of rhe mctaholism of UL-14C-lezdne and UL-14C-valine. Incubations with fibroblasts were identical to those using the I-I4C-amino acids except that the buffer was Krebs-Ringer bicarbonate, and the specific activity of the amino acids was 10-fold higher (4 mCi/mmol). After incubation for 90 min at 35" C, the reactions were stopped by placing on ice, and unlabeled standard organic acids were added. The standards for UL-I4C-leucine were I pEq of a-ketoisocaproic acid and 0.5 pEq each of P-methylcrotonic, 3-hydroxyisovaleric, P-hydroxy-P-methylglutaric, and citric acids in 87. 5 The standards for UL-I4C-valine were 1 pEq of a-ketoisovaleric acid and 0.5 pEq each of 0-hydroxyisobutyric, propionic, and citric acids in 62.5 111. The incubation mixtures with standards were adjusted to pH 12 or greater with 50 p1 of 10 moll1 NaOH and left at room temperature for 15 min to hydrolyze coenzyme A esters. Oximes of the a-ketoacids were formed by adding 10 p1 of a fresh solution of 3.6 mol/liter of hydroxylamine.HC1 and leaving at room temperature for 15 min. The 14C-organic acids were separated by acidification with 50 p1 6 mol/liter sulfuric acid and LPC or1 silicic acid as described for the a-keto and a-hydroxy acids except that a concave upward gradient of 2-methyl-2-butanol in chloroform was used, and 110 fractions were collected, dried, and counted. The total dmp in the radioactive peaks were calculated, and the dmp of the peaks from the blanks without cells were subtracted.
RESULTS
The LPC separation of the 1-I4C-branched-chain a-keto and a-hydroxy acid products of transamination are shown in Figure  1 . The amounts of 1-14C-hydroxy acids were a small fraction of the amounts of 1-I4C-keto acids. Considerably more isotope was recovered in the ketoacid analog of leucine than that of valine in control fibroblasts. There was virtually no isotope of leucine in a-hydroxyisocaproic acid but the quantity of isotope of valine in a-hydroxyisovaleric acid was about 10% of that in a-ketoisovaleric acid. The conversion of leucine to a-ketoisocaproic acid in the patient was about 75% of that of the control, while thlisotope in a-ketoisovaleric acid was about one-third in the patient of that of the control incubated with valine, but the isotope in a-hydroxyisovaleric acid in the patient was greater than that of the control. These differences did not appear to be significant.
The oxidation of l-14C-leucine and l-14C-valine to I4CO2 was linear with time for at least 90 min and also linear with the quantity of cells (Fig. 2) . The extent of oxidation was similar for the two amino acids. The formation of I4C-a-keto and a-hydroxy acids was also essentially linear for at least 90 min. The sum of the I4C-a-keto plus a-hydroxy acid analogs from l-'4C-valine was considerably less than that from l-14C-leucine. The total amounts of isotope in these organic acids was virtually identical to that in COz following incubation with leucine, while the amounts in the organic acid products were considerably smallcr than that in COz following incubation with valine. Figure 3A illustrates the effects of increasing concentrations of I-"C-leucine and I-'4C-valine on the production of I4CO2 and I4C-a-keto plus a-hydroxy acids in normal fibroblasts. The smaller amount of isotope in these organic acid products of valine than those of leucine was observed at each of the higher concentrations studied. The conversion of leucine to COZ was also greater than that of valine in this study, but this did not appear to be constant (Figs. 2 and 3 , Table I ). The concentration curves of I-'4C-leucine and 1-I4C-valine on 14C-a-keto and o!-hydroxy acids in the fibroblasts of the patient with classical MSUD (Fig. 3B) were not different from those of the control. However, oxidation of the amino acids to I4CO2 was virtually zero in the patient's cells at each concentration studied.
The data on the oxidation of I-14C-leucine and I-I4C-valine to I4CO2 were similar for the two amino acids in normal control fibroblasts (Table 1 ). The means were 2.73 and 3.66 nmol/2 X 10" cells per 90 min for leucine and valine, rcspectively. The oxidation of the amino acids to I4CO2 was markedly deficient in the fibroblasts of patients with classical or intermittent MSUD, ranging from 2.5 to 3.2% of normal for l-14C-leucine and 1.0 to 2.6% of normal for l-14C-valine. The cells of the patient with deficiency of E? were considerably more effective in the oxidation of the amino acids than the patients with MSUD. The formation of I4CO2 was 25 to 30% of normal. The patient EB with branched-chain ketoaciduria, lactic acidemia and a-ketoglutaric aciduria had a deficiency of oxidation of I-14C-leucine and 1-'T-valine to "CO. that was similar to those of the patients with MSUD at 4 and 6% of the control mean. Studies were carried out using uniformly labeled valine in order to determine the nature of the catabolic products of these amino acids in cultured human fibroblasts. The LPC profile of radioactive organic acid metabolites of UL-14C-valine in normal fibroblasts is shown in Figure 411 , along with the blank without fibroblasts (dofled line). The largest radioactive peak eluted at the position of P-hydroxyisobutyric acid. This is a metabolite in the catabolic pathway of valine, but it was unexpected that it was the major metabolic product. The peak was substantially larger than that of CY-ketoisovaleric acid, the second largest peak. The pattern of the blank incubated without fibroblasts revealed a considerable amount of contaminating isotopic material. The largest peak eluted at the position of acetic acid. This was greatly decreased in incubations with normal fibroblasts, suggesting that it was metabolized. In fibroblasts of the patient with intermittent BCKADH deficiency (Fig. 4R) there was a large amount of isotope in the peak of a-ketoisovaleric acid but almost none in fi-hydroxyisobutyric acid.
Patients with classical or intermittent MSUD converted less than 1% as much valinc to P-hydroxybutyric acid as did the control (Table 2 ). This is consistent with the finding of 1 to 3% of normal activity of BCKADH observed in the oxidation of 1-I4C-valine to I3CO2 (Table I ). In the cells of the patient with deficiency of E3 7% of the control level of isotope was found in IT-fi-hydroxyisobutyric acid (Table 2 ) and this is consistent with the greater activity of BCKADH found in the oxidation of 1-IT-valine to I4CO2 (Table 1 ). The patient with BCKADH deficiency. lactic acidemia. and CY-ketoglutaric aciduria produced 2.5% of the '4C-~-hydroxyisobutyric acid from valine as did the control cells (Table 2) . Control fibroblasts incubated with UL-IT-lclcunc produced large amounts of a-ketoisocaproic acid and a peak eluting at the position of P-hydroxyisovaleric acid as the second niost abundant metabolite (Tablc 2). P-Hydroxyisovaleric acid is presumably formed by the hydration of B-methylcrotonylCoA. The production of IT-8-hydroxyisovaleric acid from UL-"C-leucine was greatly reduced in fibroblasts of all of the patients . The lcppcr portion represents the radioactive products and the lowcr line the titratable added standard and endogcnous organic acids. The numbered peaks were 3, isobutyric and methylacrylic acids; 7, propionic acid: 10, (u-KIVA oxime and a-HIVA, 13, acetic acid; 24, formic acid: 40. 8-hydroxyisobutyric acid: 43, lactic acid: and 100. citric acid. The dotted line above in the control represents the blank without fibroblasts: 2 x IO%broblasts were incubated 90 min with I mmol/liter (4 mCi/mmol) of UL-I4C-valine and products analyzed by liquid partition chromatography as described In "Materials and Methods."
and paralleled the blank in the formation of 14C-P-hydroxyisobutyric acid from UL-'4C-valine (Table 2 ).
DISCUSSION
The metabolism of the branched-chain amino acids leucine and valine in normal cultured fibroblasts displayed certain similarities and some major differences. Oxidation of each substrate to CO. was quite similar, as studied over 120 min using 1-I4C-labeled leucine and valine. There was a close parallel between the conversion of I e~c i n e -l -~~C to I4CO2 and its conversion to CYketoisocaproic acid and its hydroxy acid. However, in the case of ~a l i n e -l -'~C there was considerably more isotope in I4CO2 than in the corresponding a-ketoisovaleric and a-hydroxy acids. The major metabolic product of valine was P-hydroxyisobutyric acid. The amounts of isotope in this compound were somewhat higher than that in the sum of a-ketoisovaleric and a-hydroxyisovaleric acids. In the metabolism of leucine, a major metabolic product was P-hydroxyisovaleric acid. In this case the amounts of isotope in this compound were about one-tenth as great as that in a-ketoisocaproic acid.
These observations indicate that leucine is normally rapidly converted in fibroblasts to P-methylcrotonyl CoA and that this compound is promptly hydrated to form P-hydroxyisovaleric acid. In normal fibroblasts valine is even more rapidly catabolized beyond the initial a-keto acid step. Accumulation is at the level of /3-hydroxyisobutyric acid. The accumulation in each instance of the /3-hydroxy acid is of interest. It could reflect a more reducing environment in the fibroblast, possibly the ratio of NADH to NAD.
The data obtained are consistent with studies of the conversion of the ketoacid analogs of the branched-chain amino acids to C 0 2 in which a-ketoisovalerate is catabolized more rapidly than a-ketoisocaproic acid. Purified branched-chain a-ketoacid dehydrogenase displays a higher rate of conversion of a-ketoisovalerate to I4CO2 than that of a-ketoisocaproate; study of the reduction of NAD revealed the same pattern; and there was a 1: 1 : I stoichiometry of I4CO2 formation, NAD reduction and acyl CoA formation (10, 11) . On the other hand, the apparent V,,, values for a-ketoisocaproic acid and a-ketoisovaleric acid as substrates for the purified dehydrogenase were very similar (l2), and this is consistent with the fact that our rates of conversion of labeled leucine and valine to 14C02 were quite similar. Apparent K,, values for the three ketoacids were very similar (1 I). In normal fibroblasts in culture, activity of branched-chain ketoacid dehydrogenase is increased by cultivation in high concentration of branched-chain amino acids, a form of regulation that is absent in intact cells with deficient dehydrogenase activity (1 3). BCKADH is a rate-limiting step in the catabolism of branchedchain amino acids and this is thought to play an important role in determining the concentrations of branched-chain amino acids in blood and tissues. The dehydrogenase appears to be regulated by covalent modification in a phosphorylation-dephosphorylation mechanism analogous to that of pyruvate dehydrogenase (1 4). a-Ketoisocaproic acid, and to a considerably lesser extent the other branched-chain ketoacids, regulate the activity of the dehydrogenase by inhibiting the kinase that catalyzes its phosphorylation, which would account for the unique properties of leucine in regulating the activity of branched-chain ketoacid dehydrogenase.
Accumulations of 8-hydroxyisovaleric acid and P-hydroxyisobutyric acid have been described as concomitants of ketosis, even in normal individuals (1 5). These compounds have been recog--nized as products of leucine and valine (15) . 0-Hydroxy-0-methylglutaryl CoA, the key intermediate in ketogenesis, has been thought not to be an intermediate in the formation of these compounds. The complete absence of conversion of the branched-chain amino acids to these hydroxy acids in cells of the patient with classic MSUD indicates that the formation of these compounds requires metabolism beyond the initial a-keto acid step, presumably to P-methylcrotonyl CoA and P-hydroxyisobutyryl CoA. There is a pathway in liver in which P-hydroxyisovaleric acid may be formed from a-ketoisocaproic acid in a reaction catalyzed by a-ketoisocaproate oxidase (1 6, 17). Our data indicate that this pathway is not normally present in cultured human fibroblasts, since there was no conversion to this product in cells of the patient with MSUD. Thus in normal fibroblasts all of the P-hydroxyisovaleric acid formed must come via the usual pathway which is blocked in MSUD.
The patients with defects in metabolism all had defective conversion of leucine and valine to 14C02. Furthermore, the patients with associated defective metabolism of pyruvate and aketoglutarate had much less complete deficiency in these oxidative decarboxylations. However, among the patients with branched-chain ketoaciduria and clinical manifestations oi F MSUD the conversion of l e~c i n e -l -'~C was virtually identical in the patient with classic MSUD and two patients with an intermittent clinical phenotype. The amount of isotope of valine-1.-I4C in I4CO2 in these two patients was more than twice that o:F the patient with classic MSUD, but these values represented only 2.7 versus 1 % of the control mean. These data do not seem to indicate that valine is any better tracer than leucine in distinguishing among different variants of the BCKADH. Although there was somewhat higher residual activity in the patients with intermittent branched ketoaciduria when valine was the substrate, the SDs were sufficiently great that these differences do not appear to be significant.
The oxidation of leucine to C 0 2 has generally been employed in the assay of BCKADH, and it is reliable in the demonstration of low rates of production of C 0 2 from leucine in fibroblasts O F patients with MSUD; while a-ketoisocaproic acid may not be a reliable substrate for this purpose because normal rates of decarboxylation may be seen when substrate concentrations are high (18, 19) . In the presence of high extracellular concentrations of the keto acid its intracellular concentrations become very high and there is a low affinity decarboxylating system, present in patients with MSUD as well as normals, which acts on a,-ketoisocaproic acid at high concentrations (6, 18, (20) (21) (22) (23) . When leucine is the substrate intracellular concentrations remain low (20) ; thus the amino acid is a better substrate than the keto acid for demonstration of the defect in patients with MSUD. Furthermore, blanks are lower when the amino acid is used.
Assessment of the conversion of labeled leucine or valine to their major metabolic products distal to the block provides alternative approaches to the assay of BCKADH activity in various patients. In classic MSUD we found the conversion of valine to P-hydroxyisobutyrate and of leucine to 0-hydroxyisovalerate to be zero. In patients with secondary defects in which there was also defective metabolism of pyruvate and a-ketoglutarate there were appreciable amounts of isotope in these products and at the same time clear evidence of deficiency. The conversion of leucine to 0-hydroxyisovaleric acid in the two patients was 4.5% of control. Similarly in the patient in whom E3 was normal the conversion of valine to P-hydroxyisovaleric acid was 2.5% of control. In the patient with E3 deficiency the value was 7.7% of control. In both of the variants with the intermittent phenotype there was isotope in P-hydroxyisovalerate after incubation with leucine. After incubation with valine there was evidence of isotope in P-hydroxyisobutyric acid in only one of the two patients, but the amount was more than following leucine. These observations suggest that simple demonstration of defective oxidation of leucine to COz should be sufficient for the characterization of a patient with classic MSUD. On the other hand, the careful study of patients with variant forms may be elucidated by a metabolic study in which the major metabolic products are determined. In this study this proved not to be the case for those patients with the intermittent phenotype. Of those with the associated deficiency of metabolism of a-ketoglutarate and pyruvate, distinction from classic MSUD could readily be made by the study of COz or the metabolic products. The distinction of EB from those with the intermittent phenotype was better using the LPC method. That these kinds of data may have clinical relevance is suggested by the report of a patient with intermittent MSUD who appeared to be valine toxic (24) .
In the leucine metabolism of fibroblasts as well as other nonhepatic tissues, the dehydrogenase reaction of the branchedchain ketoacid is thought to be limiting (20, (25) (26) (27) . This is consistent with the fact that the concentrations of a-ketoisocaproic acid in fibroblasts of patients with MSUD are not much lower than those of control fibroblasts (20) . It is also consistent that in our studies the amounts of isotope in P-hydroxyisovaleric acid were considerable, but smaller than that in a-ketoisocaproic acid following the incubation of control fibroblasts with leucine. On the other hand, the observations that there are substantial accumulations of P-hydroxyisovaleric acid in normal fibroblasts suggest that the carboxylation of /3-methylcrotonyl CoA may also be limiting and that this compound is then hydrated to form Phydroxyisovaleric acid. In the metabolism of valine the amounts of isotope in 8-hydroxyisobutyric acid were considerably greater than in a-ketoisovaleric acid, suggesting that in the case of this amino acid the BCKADH step is not the limiting one.
